Prevention of drug absorption in simulated theophylline overdose

Clinical Toxicology

Volumn 33, Issue 1, 1995, Pages 43-49

  Minton, Neil A ^a   Hentry, John A ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Activated charcoal; Catharsis; Overdose; Sorbitol; Sustained release theophylline

Indexed keywords

ACTIVATED CARBON; CHARCOAL; PLACEBO; SORBITOL; THEOPHYLLINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG OVERDOSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PSYCHOTHERAPY; SUSTAINED RELEASE PREPARATION;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; CATHARSIS; CHARCOAL; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HALF-LIFE; HUMANS; INTESTINAL ABSORPTION; MALE; OVERDOSE; SORBITOL; THEOPHYLLINE;

EID: 0028833422     PISSN: 15563650     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659509020214     Document Type: Article

References (40)

1. Theophylline poisoning. Pharmacological considerations and clinical management
2. Fatal overdose from a sustained-release theophylline preparation
3. Aminophylline toxicity-how many hospital asthma deaths does it cause
4. Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates and ethanol
5. Pharmacokinetic interactions between theophylline and other medication (Part I)
6. Pharmacokinetic interactions between theophylline and other medication (Part II)
7. Studies on the efficacy of gastric lavage as practiced in a large metropolitan hospital
8. Activated charcoal, emesis, and gastric lavage in aspirin overdose
9. Oral activated charcoal to enhance theophylline elimination in an acute overdose
10. Inefficacy of gastric emptying procedures
11. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charocoal for acute durg overdose
12. Syrup of ipeacauanha: is it really useful
13. An investigation into methods of prevention of theophylline absorption from accidental or deliberate overdose
14. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve
15. Role of repeated oral doses of activated charcoal in clinical toxicology
16. Gastrointestinal clearance of drugs with activated charcoal
17. Enhancement of theophylline clearance by oral activated charcoal
18. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline
19. The comparative efficacy of various multiple-dose activated charcoal regimens
20. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal
21. Increased serum theophylline clearance with orally administered activated charcoal
22. Effects of the size and frequency of oral doses of charcoal on theophylline clearance
23. Model for theophylline overdose treatment with oral activated charcoal
24. Self-poisoning with theophylline. The effect of repeated doses oral charcoal on drug elimination
25. Multiple dose activated charcoal for theophylline poisoning in young infants
26. Treatment of theophylline overdose with oral activated charcoal
27. Gastrointestinal transit times of cathartics combined with charcoal
28. The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation
29. Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose
30. Gastrointestinal obstruction associated with multiple dose of activated charcoal
31. Effect of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal
32. Absorbent and cathartic inhibition of enteral drug absorption
33. Management of theophylline overdose patients in the Intensive Care Unit
34. Characteristics of vomiting associated with sustained release theophylline poisoning: implications for management with oral activated charcoal
35. Poor tolerance of oral activated charcoal with theophylline overdose
36. Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity
37. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication
38. Ondansetron in the treatment of theophylline overdose
39. Effect of purgatives on antidotal efficacy of oral activated charcoal
40. Haemoperfusion for theophylline overdose